Pliant Therapeutics Inc (PLRX) Price Prediction & ForecastPLRXPliant Therapeutics Inc

Alphio's PLRX stock price prediction model matches the current Pliant Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.80 (-0.70%). The 1-week path is $0.78 (-3.53%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Pliant Therapeutics Inc is currently trading at $0.8392, which is very close to its 52-week low of $0.83. The RSI is at 30.592, indicating that the stock is oversold, but the company continues to report significant losses, with a net income loss of $23.577 million in Q4 2025. While there are some positive developments in their oncology focus, the overall financial performance and recent stock decline suggest caution. The main risk is the company's ongoing negative earnings, with an EPS of -0.36 reported last quarter, which raises concerns about its profitability moving forward.

Pliant Therapeutics Inc (PLRX) last closed at $0.8063, losing -1.16%. These facts feed the 1-day and 1-week PLRX price prediction above.